Fatty liver: role of inflammation and fatty acid nutrition

by Byrne, Christopher D.
Published 2010

Editorial. Time to rethink high-density lipoprotein?

by Wild, Sarah, Byrne, Christopher D.
Published 2008

There is a slight increase in incident diabetes risk with the use of statins, but benefits likely outweigh any adverse effects in those with moderate-to-high cardiovascular risk

by Bhatia, Lokpal, Byrne, Christopher D.
Published 2010

NAFLD: A multisystem disease

by Byrne, Christopher D., Targher, Giovanni
Published 2015

Circulating markers of liver function and cardiovascular disease risk

by Targher, Giovanni, Byrne, Christopher D.
Published 2015

Importance of early recognition of heterozygous familial hypercholesterolaemia

by Ryan, A., Byrne, Christopher D.
Published 2015

Gallstone disease and increased risk of ischemic heart disease: causal association or epiphenomenon?

by Targher, G., Byrne, Christopher D.
Published 2015

Time to replace assessment of liver histology with MR-based imaging tests to assess efficacy of interventions for nonalcoholic fatty liver disease

by Byrne, Christopher D., Targher, Giovanni
Published 2015

Current treatment of non-alcoholic fatty liver disease

by Ahmed, Mohamed H., Byrne, Christopher D.
Published 2008

Editorial. Body fat and increased risk of cirrhosis: better diagnosis and treatment of non-alcoholic fatty liver disease are needed.

by Byrne, Christopher D., Wild, S.H
Published 2010

Bariatric surgery and renal function: a precarious balance between benefit and harm

by Ahmed, Mohamed H., Byrne, Christopher D.
Published 2010

Ezetimibe as a potential treatment for non alcoholic fatty liver disease: is the intestine a modulator of hepatic insulin sensitivity and hepatic fat accumulation?

by Ahmed, Mohamed H., Byrne, Christopher D.
Published 2010